Environmental Estrogen Screening

Overview

Environmental estrogens are chemicals that can mimic or interfere with natural estrogen signaling. They may be present in pharmaceuticals, pesticides, industrial chemicals, plastic additives, personal care products, wastewater, and other environmental pollutants. In aquatic organisms, these chemicals may affect growth, development, sex differentiation, and reproductive function.

Our zebrafish environmental estrogen screening service evaluates estrogen-related activity and toxicity in a whole-organism model. The platform combines transgenic fluorescence reporter assays with developmental, phenotypic, and optional molecular endpoints. It can be used for early hazard identification, compound prioritization, endocrine disruptor research, and environmental risk assessment.

The service is suitable for single compounds, analog series, metabolites, degradation products, mixtures, and selected environmental sample extracts.

Regulatory Relevance

Study designs can be developed with reference to recognized endocrine disruption and fish ecotoxicology testing frameworks. Depending on project goals, assays may be aligned with relevant OECD testing principles and estrogen receptor-related adverse outcome pathway concepts.

Relevant reference frameworks may include:

• OECD Fish Embryo Acute Toxicity Test (TG 236)
• OECD Fish Early-Life Stage Toxicity Test (TG 210)
• OECD Fish Short-Term Reproduction Assay (TG 229)
• OECD Fish Sexual Development Test (TG 234)
• Estrogen receptor activation-related adverse outcome pathway concepts

Key Advantages

1

Sensitive in vivo evaluation of estrogenic activity

2

Whole-organism assessment of endocrine-related effects

3

Multiple endpoints for estrogen pathway analysis

4

Suitable for environmental chemical screening

5

Quantitative fluorescence and molecular analysis

6

Flexible study designs for different research objectives

Service Details

Our environmental estrogen screening platform uses zebrafish models to identify compounds capable of activating or disrupting estrogen-related pathways. Assays can be customized based on chemical characteristics, exposure conditions, and evaluation objectives.

Estrogenic Activity Assessment

Compounds are evaluated for their potential to induce estrogen-related biological responses, including:

• Estrogen-responsive phenotypic changes
• Alterations in reproductive development
• Growth and developmental effects
• Sex-related physiological changes (optional)

Estrogen Pathway Reporter Analysis

Transgenic zebrafish models can be used to monitor estrogen signaling activation through fluorescence-based approaches.

Assessment options include:

• Estrogen receptor (ER)-mediated pathway activation
• Tissue-specific fluorescence responses
• Spatial distribution of estrogen signaling activity
• Quantitative fluorescence intensity analysis

Reproductive and Developmental Effects

Environmental estrogens may affect reproductive-related processes. Evaluation may include:

• Gonadal development
• Reproductive organ morphology
• Developmental abnormalities
• Growth-related effects
• Long-term exposure responses (optional)

Workflow

Endpoints

Data Analysis

Data analysis can include:

• Concentration-response curves
• Relative potency comparison with a reference estrogen
• EC10, EC20, or EC50 estimation, where appropriate
• LOEC or NOEC assessment, where applicable
• Fluorescence intensity normalization
• Tissue-specific response quantification
• Statistical comparison between treatment groups
• Compound ranking and data visualization

Estrogen reporter responses are considered alongside survival, morphology, growth, and developmental status. Results can therefore be categorized as:

• Estrogen receptor-associated activity
• Anti-estrogenic or estrogen-modulating activity
• General developmental or systemic toxicity
• Fluorescence-related interference
• Inconclusive findings requiring follow-up studies

Why Choose Us

Our zebrafish platform provides quantitative assessment of environmental estrogen activity and endocrine-related toxicity.

FAQ